AAPL344.58-4.33 (-1.24%) ▼|ABBV295.89+5.10 (+1.75%) ▲|ABT105.88+1.31 (+1.25%) ▲|ACN258.78+11.56 (+4.68%) ▲|ADBE249.86+1.74 (+0.70%) ▲|AMAT385.99-35.67 (-8.46%) ▼|AMD498.33-68.09 (-12.02%) ▼|AMGN469.17+8.44 (+1.83%) ▲|AMT189.49+3.61 (+1.94%) ▲|AMZN238.81-4.98 (-2.04%) ▼|AVGO321.30-23.71 (-6.87%) ▼|AXP317.93-5.78 (-1.79%) ▼|BA170.69-1.97 (-1.14%) ▼|BAC49.87-1.27 (-2.48%) ▼|BKNG148.25-2.18 (-1.45%) ▼|BLK1,141.53-34.72 (-2.95%) ▼|BMY62.92+1.53 (+2.49%) ▲|BNY146.22-3.16 (-2.11%) ▼|BRK-B544.05+2.09 (+0.39%) ▲|C121.41-4.35 (-3.46%) ▼|CAT625.45-21.95 (-3.39%) ▼|CL96.22+3.06 (+3.28%) ▲|CMCSA23.00+0.73 (+3.26%) ▲|COF203.20-5.54 (-2.65%) ▼|COP152.88+2.85 (+1.90%) ▲|COST1,019.47+24.86 (+2.50%) ▲|CRM229.37-1.53 (-0.66%) ▼|CSCO104.34-4.25 (-3.91%) ▼|CVS90.70+0.37 (+0.41%) ▲|CVX234.85+3.39 (+1.46%) ▲|DE670.08+10.08 (+1.53%) ▲|DHR231.11-5.88 (-2.48%) ▼|DIS110.96+0.05 (+0.05%) ▲|DUK128.04+2.14 (+1.70%) ▲|EMR164.52-6.22 (-3.64%) ▼|FDX317.08+9.26 (+3.01%) ▲|GD374.12+3.30 (+0.89%) ▲|GE301.36-11.69 (-3.73%) ▼|GEV851.88-35.97 (-4.05%) ▼|GILD172.37+6.76 (+4.08%) ▲|GM87.50+1.78 (+2.08%) ▲|GOOG275.98-6.34 (-2.25%) ▼|GOOGL277.81-6.02 (-2.12%) ▼|GS881.92-45.81 (-4.94%) ▼|HD329.52+0.54 (+0.16%) ▲|HON220.40-1.75 (-0.79%) ▼|IBM256.03-2.26 (-0.87%) ▼|INTC63.65-28.43 (-30.87%) ▼|INTU340.74+9.55 (+2.88%) ▲|ISRG434.98-13.78 (-3.07%) ▼|JNJ275.74+0.54 (+0.20%) ▲|JPM336.11-7.47 (-2.17%) ▼|KO94.50+1.68 (+1.80%) ▲|LIN515.52+12.37 (+2.46%) ▲|LLY1,424.35+50.65 (+3.69%) ▲|LMT638.96-4.63 (-0.72%) ▼|LOW209.47+2.19 (+1.05%) ▲|LRCX233.44-20.96 (-8.24%) ▼|MA638.75+3.05 (+0.48%) ▲|MCD259.12+1.74 (+0.67%) ▲|MDLZ65.10+2.57 (+4.11%) ▲|MDT96.62-0.50 (-0.51%) ▼|META614.98-9.54 (-1.53%) ▼|MMM174.24-3.12 (-1.76%) ▼|MO78.51+1.76 (+2.29%) ▲|MRK150.17+3.84 (+2.62%) ▲|MS182.31-6.54 (-3.46%) ▼|MSFT520.78-9.36 (-1.77%) ▼|MU865.78-68.50 (-7.33%) ▼|NEE84.25+2.11 (+2.57%) ▲|NFLX61.94-0.12 (-0.19%) ▼|NKE38.83+0.41 (+1.05%) ▲|NOW103.76-5.91 (-5.39%) ▼|NVDA202.22-11.44 (-5.35%) ▼|ORCL130.08-9.48 (-6.79%) ▼|PEP138.28+4.49 (+3.36%) ▲|PFE30.55+0.60 (+2.01%) ▲|PG162.82+2.23 (+1.39%) ▲|PLTR184.51-11.91 (-6.06%) ▼|PM209.11+0.61 (+0.29%) ▲|QCOM162.40-23.02 (-12.41%) ▼|RTX201.04+1.64 (+0.82%) ▲|SBUX103.90-1.61 (-1.53%) ▼|SCHW87.74-1.73 (-1.93%) ▼|SO94.10+1.11 (+1.19%) ▲|SPG218.08+2.36 (+1.09%) ▲|T21.45+0.53 (+2.51%) ▲|TMO692.69-16.49 (-2.33%) ▼|TMUS158.02+10.73 (+7.28%) ▲|TSLA394.93-8.37 (-2.08%) ▼|TXN295.63-15.79 (-5.07%) ▼|UBER65.01-0.73 (-1.11%) ▼|UNH408.73-2.18 (-0.53%) ▼|UNP302.84+0.91 (+0.30%) ▲|UPS108.28+0.95 (+0.89%) ▲|USB59.30-1.34 (-2.21%) ▼|V415.56+5.02 (+1.22%) ▲|VZ45.07+1.41 (+3.22%) ▲|WFC83.17-1.64 (-1.93%) ▼|WMT124.02+2.77 (+2.28%) ▲|XOM185.94+2.65 (+1.45%) ▲|AAPL344.58-4.33 (-1.24%) ▼|ABBV295.89+5.10 (+1.75%) ▲|ABT105.88+1.31 (+1.25%) ▲|ACN258.78+11.56 (+4.68%) ▲|ADBE249.86+1.74 (+0.70%) ▲|AMAT385.99-35.67 (-8.46%) ▼|AMD498.33-68.09 (-12.02%) ▼|AMGN469.17+8.44 (+1.83%) ▲|AMT189.49+3.61 (+1.94%) ▲|AMZN238.81-4.98 (-2.04%) ▼|AVGO321.30-23.71 (-6.87%) ▼|AXP317.93-5.78 (-1.79%) ▼|BA170.69-1.97 (-1.14%) ▼|BAC49.87-1.27 (-2.48%) ▼|BKNG148.25-2.18 (-1.45%) ▼|BLK1,141.53-34.72 (-2.95%) ▼|BMY62.92+1.53 (+2.49%) ▲|BNY146.22-3.16 (-2.11%) ▼|BRK-B544.05+2.09 (+0.39%) ▲|C121.41-4.35 (-3.46%) ▼|CAT625.45-21.95 (-3.39%) ▼|CL96.22+3.06 (+3.28%) ▲|CMCSA23.00+0.73 (+3.26%) ▲|COF203.20-5.54 (-2.65%) ▼|COP152.88+2.85 (+1.90%) ▲|COST1,019.47+24.86 (+2.50%) ▲|CRM229.37-1.53 (-0.66%) ▼|CSCO104.34-4.25 (-3.91%) ▼|CVS90.70+0.37 (+0.41%) ▲|CVX234.85+3.39 (+1.46%) ▲|DE670.08+10.08 (+1.53%) ▲|DHR231.11-5.88 (-2.48%) ▼|DIS110.96+0.05 (+0.05%) ▲|DUK128.04+2.14 (+1.70%) ▲|EMR164.52-6.22 (-3.64%) ▼|FDX317.08+9.26 (+3.01%) ▲|GD374.12+3.30 (+0.89%) ▲|GE301.36-11.69 (-3.73%) ▼|GEV851.88-35.97 (-4.05%) ▼|GILD172.37+6.76 (+4.08%) ▲|GM87.50+1.78 (+2.08%) ▲|GOOG275.98-6.34 (-2.25%) ▼|GOOGL277.81-6.02 (-2.12%) ▼|GS881.92-45.81 (-4.94%) ▼|HD329.52+0.54 (+0.16%) ▲|HON220.40-1.75 (-0.79%) ▼|IBM256.03-2.26 (-0.87%) ▼|INTC63.65-28.43 (-30.87%) ▼|INTU340.74+9.55 (+2.88%) ▲|ISRG434.98-13.78 (-3.07%) ▼|JNJ275.74+0.54 (+0.20%) ▲|JPM336.11-7.47 (-2.17%) ▼|KO94.50+1.68 (+1.80%) ▲|LIN515.52+12.37 (+2.46%) ▲|LLY1,424.35+50.65 (+3.69%) ▲|LMT638.96-4.63 (-0.72%) ▼|LOW209.47+2.19 (+1.05%) ▲|LRCX233.44-20.96 (-8.24%) ▼|MA638.75+3.05 (+0.48%) ▲|MCD259.12+1.74 (+0.67%) ▲|MDLZ65.10+2.57 (+4.11%) ▲|MDT96.62-0.50 (-0.51%) ▼|META614.98-9.54 (-1.53%) ▼|MMM174.24-3.12 (-1.76%) ▼|MO78.51+1.76 (+2.29%) ▲|MRK150.17+3.84 (+2.62%) ▲|MS182.31-6.54 (-3.46%) ▼|MSFT520.78-9.36 (-1.77%) ▼|MU865.78-68.50 (-7.33%) ▼|NEE84.25+2.11 (+2.57%) ▲|NFLX61.94-0.12 (-0.19%) ▼|NKE38.83+0.41 (+1.05%) ▲|NOW103.76-5.91 (-5.39%) ▼|NVDA202.22-11.44 (-5.35%) ▼|ORCL130.08-9.48 (-6.79%) ▼|PEP138.28+4.49 (+3.36%) ▲|PFE30.55+0.60 (+2.01%) ▲|PG162.82+2.23 (+1.39%) ▲|PLTR184.51-11.91 (-6.06%) ▼|PM209.11+0.61 (+0.29%) ▲|QCOM162.40-23.02 (-12.41%) ▼|RTX201.04+1.64 (+0.82%) ▲|SBUX103.90-1.61 (-1.53%) ▼|SCHW87.74-1.73 (-1.93%) ▼|SO94.10+1.11 (+1.19%) ▲|SPG218.08+2.36 (+1.09%) ▲|T21.45+0.53 (+2.51%) ▲|TMO692.69-16.49 (-2.33%) ▼|TMUS158.02+10.73 (+7.28%) ▲|TSLA394.93-8.37 (-2.08%) ▼|TXN295.63-15.79 (-5.07%) ▼|UBER65.01-0.73 (-1.11%) ▼|UNH408.73-2.18 (-0.53%) ▼|UNP302.84+0.91 (+0.30%) ▲|UPS108.28+0.95 (+0.89%) ▲|USB59.30-1.34 (-2.21%) ▼|V415.56+5.02 (+1.22%) ▲|VZ45.07+1.41 (+3.22%) ▲|WFC83.17-1.64 (-1.93%) ▼|WMT124.02+2.77 (+2.28%) ▲|XOM185.94+2.65 (+1.45%) ▲|
20.9 C
New York
Friday, October 30, 2026

Tag: commercial

newsFORsourcecompanycontentinformationreleases1market

Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision

WARREN, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the Company’s significant insider ownership of outstanding common stock, as most recently reported on July 10, 2025, on Form 8-K filed with the Securities and Exchange Commission.

Banque Fédérative du Crédit Mutuel – 2025 half-year results press release

First half of 2025:
very strong business activity and solid results,
penalized by the non-recurring income tax surcharge

KLÉPIERRE: FIRST-HALF 2025 RESULTS: CONTINUED UNABATED GROWTH

PRESS RELEASE

KLÉPIERRE: RÉSULTATS SEMESTRIELS 2025 : LA FORTE CROISSANCE SE POURSUIT

COMMUNIQUÉ DE PRESSE

Canada’s Fertilizer Future Breaks Ground at Port of Johnstown

V6 Agronomy Launches Low-Carbon Terminal to Reshore Critical Supply Chains JOHNSTOWN, ON, July 30, 2025 /CNW/ - On July 29, a shovel hit the ground in the Township of Edwardsburgh Cardinal (TWPEC),...

Ohio Cannabis Retailer The Botanist Opens Solon’s First Dispensary

SOLON, Ohio, July 30, 2025 /PRNewswire/ -- The Botanist, Ohio's premier cannabis brand, today announced the opening of its sixth in-state dispensary at 33113...

Final results

FORESIGHT VENTURES VCT PLC
LEI: 213800R88MRC4Y3OIW86
29 July 2025

PuroClean Sets Sights on Massachusetts for Strategic Franchise Expansion

Fifteen Territories Available Across Boston, the Coast, and Key Metro Areas; In-Market PROPEL Event Scheduled for July 30-31 TAMARAC, Fla., July 30, 2025 /PRNewswire/ --...

Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer’s Association International Conference (AAIC) 2025

TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI®), an anti-Aβ protofibril* antibody, was presented at the Alzheimer's Association International Conference (AAIC) 2025, held in Toronto, Canada and virtually. Only lecanemab fights AD in two ways – targeting both amyloid plaque and protofibrils*, which can impact tau downstream.

Solidec Raises Oversubscribed $2M Pre-Seed Round to Reinvent Chemical Manufacturing

HOUSTON, July 30, 2025 /PRNewswire/ -- Solidec, a pioneer in clean chemical manufacturing, today announced it has raised $2+ million in pre-seed funding led by...

EuMentis Therapeutics Receives U.S. FDA Clearance of IND Application for EM-221, a Novel PDE10A Inhibitor for Schizophrenia

-Company expects to initiate Phase 2 study in 2H 2025- SAN DIEGO, July 30, 2025 /PRNewswire/ -- EuMentis Therapeutics, Inc., ("EuMentis"), a clinical-stage drug development company...

Vystar Introduces New RxAir-800 Replacement Cartridge Extended Life UV-C Bulb

New RxAir400 Pro UV-C bulb replacement cartridge provides 18,000 vs 9,000 hr. use.

PropertyTek Names Ashley Sweet as VP of Enterprise Solutions

Sweet brings more than a decade of proptech and CRE sales leadership to drive growth across ShowMojo and Tenant Turner.

OLI Systems Secures $400K DOE Contract Extension to Advance Thermodynamic Modeling for Critical Materials

PARSIPPANY, N.J., July 30, 2025 /PRNewswire/ -- OLI Systems, a global leader in water chemistry simulation, has received $400,000 in research funding through a...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCommercial

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers